BIOMAT Database Logo BIOMAT Database Logo

Bortezomib: A New Promising Therapy for Early Antibody-Mediated Rejection After Liver Transplantation? 2019

Marcio F Chedid, and Emilio Rodrigo
Liver and Pancreas Transplant and Hepatobiliary Surgery Unit, Hospital de Clinicas de Porto Alegre, Medical School of UFRGS, Porto Alegre, Brazil.

UI MeSH Term Description Entries

Related Publications

Marcio F Chedid, and Emilio Rodrigo
Bortezomib for acute antibody-mediated rejection in liver transplantation.
September 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
Marcio F Chedid, and Emilio Rodrigo
Bortezomib rescue therapy in a patient with recurrent antibody-mediated rejection after lung transplantation.
December 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
Marcio F Chedid, and Emilio Rodrigo
Proteasome inhibition with bortezomib: an effective therapy for severe antibody mediated rejection after renal transplantation.
March 2012, Clinical nephrology,
Marcio F Chedid, and Emilio Rodrigo
The Effect of Bortezomib on Antibody-Mediated Rejection after Kidney Transplantation.
November 2015, Yonsei medical journal,
Marcio F Chedid, and Emilio Rodrigo
1.7 year follow-up after bortezomib therapy for refractory antibody mediated rejection.
January 2010, Clinical transplants,
Marcio F Chedid, and Emilio Rodrigo
[THE USE OF BORTEZOMIB FOR THE TREATMENT OF CHRONIC ANTIBODY MEDIATED REJECTION AFTER KIDNEY TRANSPLANTATION].
January 2018, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
Marcio F Chedid, and Emilio Rodrigo
Bortezomib as rescue therapy for antibody mediated rejection: a single-center experience.
January 2010, Clinical transplants,
Marcio F Chedid, and Emilio Rodrigo
Reduction in proteinuria with bortezomib based therapy for antibody mediated rejection.
January 2010, Clinical transplants,
Marcio F Chedid, and Emilio Rodrigo
Bortezomib provides effective therapy for antibody- and cell-mediated acute rejection.
December 2008, Transplantation,
Marcio F Chedid, and Emilio Rodrigo
Dual Antibody Treatment for Simultaneous Acute Cellular Rejection and Antibody-Mediated Rejection After Liver Transplantation: A Case Report.
October 2023, Transplantation proceedings,
Copied contents to your clipboard!